BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33050002)

  • 1. Antiproliferative and Antimigration Activities of Beauvericin Isolated from
    Yahagi H; Yahagi T; Furukawa M; Matsuzaki K
    Molecules; 2020 Oct; 25(19):. PubMed ID: 33050002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isariotins E and F, spirocyclic and bicyclic hemiacetals from the entomopathogenic fungus Isaria tenuipes BCC 12625.
    Bunyapaiboonsri T; Yoiprommarat S; Intereya K; Rachtawee P; Hywel-Jones NL; Isaka M
    J Nat Prod; 2009 Apr; 72(4):756-9. PubMed ID: 19265430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deguelin suppresses pancreatic tumor growth and metastasis by inhibiting epithelial-to-mesenchymal transition in an orthotopic model.
    Boreddy SR; Srivastava SK
    Oncogene; 2013 Aug; 32(34):3980-91. PubMed ID: 22986522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of pancreatic cancer stem cell characteristics by α-Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog.
    Ma Y; Yu W; Shrivastava A; Srivastava RK; Shankar S
    J Cell Mol Med; 2019 Apr; 23(4):2719-2730. PubMed ID: 30712329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ellagic acid inhibits the proliferation of human pancreatic carcinoma PANC-1 cells in vitro and in vivo.
    Cheng H; Lu C; Tang R; Pan Y; Bao S; Qiu Y; Xie M
    Oncotarget; 2017 Feb; 8(7):12301-12310. PubMed ID: 28135203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor activity of cediranib, a pan-vascular endothelial growth factor receptor inhibitor, in pancreatic ductal adenocarcinoma cells.
    Momeny M; Alishahi Z; Eyvani H; Esmaeili F; Zaghal A; Ghaffari P; Tavakkoly-Bazzaz J; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
    Cell Oncol (Dordr); 2020 Feb; 43(1):81-93. PubMed ID: 31512195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic Activities and Molecular Mechanisms of the Beauvericin and Beauvericin G
    Lim HN; Jang JP; Shin HJ; Jang JH; Ahn JS; Jung HJ
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32340351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of MUC1 induces apoptosis and inhibits migration in pancreatic cancer PANC-1 cells via regulation of Slug pathway.
    Zhao P; Meng M; Xu B; Dong A; Ni G; Lu L
    Cancer Biomark; 2017 Dec; 20(4):469-476. PubMed ID: 28869438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of MIST1 reverses the epithelial-mesenchymal transition and reduces the tumorigenicity of pancreatic cancer cells via the Snail/E-cadherin pathway.
    Li X; Chen H; Liu Z; Ye Z; Gou S; Wang C
    Cancer Lett; 2018 Sep; 431():96-104. PubMed ID: 29859299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The preclinical evaluation of TIC10/ONC201 as an anti-pancreatic cancer agent.
    Zhang Q; Wang H; Ran L; Zhang Z; Jiang R
    Biochem Biophys Res Commun; 2016 Aug; 476(4):260-266. PubMed ID: 27233611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local Delivery of Gemcitabine Inhibits Pancreatic and Cholangiocarcinoma Tumor Growth by Promoting Epidermal Growth Factor Receptor Degradation.
    Jang SI; Fang S; Baek YY; Lee DH; Na K; Lee SY; Lee DK
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32111094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taurolidine induces epithelial-mesenchymal transition via up-regulation of the transcription factor Snail in human pancreatic cancer cell lines.
    Hotz B; Erben U; Arndt M; Buhr HJ; Hotz HG
    Int J Colorectal Dis; 2014 Nov; 29(11):1339-48. PubMed ID: 25179425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oridonin inhibition and miR‑200b‑3p/ZEB1 axis in human pancreatic cancer.
    Gui Z; Luo F; Yang Y; Shen C; Li S; Xu J
    Int J Oncol; 2017 Jan; 50(1):111-120. PubMed ID: 27878247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MIF inhibitor, ISO-1, attenuates human pancreatic cancer cell proliferation, migration and invasion in vitro, and suppresses xenograft tumour growth in vivo.
    Cheng B; Wang Q; Song Y; Liu Y; Liu Y; Yang S; Li D; Zhang Y; Zhu C
    Sci Rep; 2020 Apr; 10(1):6741. PubMed ID: 32317702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Epithelial-Mesenchymal Transition for Identification of Inhibitors for Pancreatic Cancer Cell Invasion and Tumor Spheres Formation.
    Polireddy K; Dong R; McDonald PR; Wang T; Luke B; Chen P; Broward M; Roy A; Chen Q
    PLoS One; 2016; 11(10):e0164811. PubMed ID: 27764163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liraglutide suppresses the metastasis of PANC-1 co-cultured with pancreatic stellate cells through modulating intracellular calcium content.
    Zhao H; Jiang X; Duan L; Yang L; Wang W; Ren Z
    Endocr J; 2019 Dec; 66(12):1053-1062. PubMed ID: 31474673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mahanimbine Exerts Anticancer Effects on Human Pancreatic Cancer Cells by Triggering Cell Cycle Arrest, Apoptosis, and Modulation of AKT/Mammalian Target of Rapamycin (mTOR) and Signal Transducer and Activator of Transcription 3 (STAT3) Signalling Pathways.
    Pei C; He Q; Liang S; Gong X
    Med Sci Monit; 2018 Oct; 24():6975-6983. PubMed ID: 30273298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chinese Propolis Suppressed Pancreatic Cancer Panc-1 Cells Proliferation and Migration via Hippo-YAP Pathway.
    Tao L; Chen X; Zheng Y; Wu Y; Jiang X; You M; Li S; Hu F
    Molecules; 2021 May; 26(9):. PubMed ID: 34068565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monensin inhibits cell proliferation and tumor growth of chemo-resistant pancreatic cancer cells by targeting the EGFR signaling pathway.
    Wang X; Wu X; Zhang Z; Ma C; Wu T; Tang S; Zeng Z; Huang S; Gong C; Yuan C; Zhang L; Feng Y; Huang B; Liu W; Zhang B; Shen Y; Luo W; Wang X; Liu B; Lei Y; Ye Z; Zhao L; Cao D; Yang L; Chen X; Haydon RC; Luu HH; Peng B; Liu X; He TC
    Sci Rep; 2018 Dec; 8(1):17914. PubMed ID: 30559409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of 2-Substituted Benzothiazole Derivatives and Their
    Uremis N; Uremis MM; Tolun FI; Ceylan M; Doganer A; Kurt AH
    Anticancer Res; 2017 Nov; 37(11):6381-6389. PubMed ID: 29061823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.